Related Content
Learn more
poster
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
FixVUE, InSituPlex
Learn more
ebook
Fast and accurate spatial phenotyping and immuno-profiling using Ultivue UltiMapper kits and the ZEISS Axioscan 7 slide scanner
Ultivue
Collaboration, FixVUE, InSituPlex
Learn more
webinar
Introduction to Ultivue’s capabilities for immuno-oncology biomarker programs
Moritz Widmaier, PhD; Branden Hopkinson, PhD
Length: 20 minutes
FlexVUE, InSituPlex
Learn more
webinar
UltiStacker for mIF
Doug Wood, PhD
Length: 17 minutes
FixVUE, FlexVUE, InSituPlex, U-VUE
Learn more
poster
A multiplex immunofluorescence assay to assess immune checkpoint inhibitor targeted CD8 activation and tumor co-localization in FFPE tissues Copy
Collaboration, FixVUE, InSituPlex





